Skip to main content
Premium Trial:

Request an Annual Quote

Innovative Biosensors Nets $3.5M in Series A to Develop Pathogen Detectors

NEW YORK, May 27 (GenomeWeb News) - Innovative Biosensors has raised $3.5 million of venture capital in a Series A round, the College Park, Md.-based company said yesterday.

 

The company, founded in 2003, uses technology licensed from the Massachusetts Institute of Technology to develop sensitive and fast pathogen detectors for food testing and clinical diagnostics.

 

Harbert Venture Partners led the financing round and was joined by New Markets Growth Fund and the Maryland Venture Fund.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.